Illinois Municipal Retirement Fund Sells 27,103 Shares of Henry Schein, Inc. $HSIC

Illinois Municipal Retirement Fund reduced its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 26.7% in the second quarter, according to its most recent filing with the SEC. The fund owned 74,335 shares of the company’s stock after selling 27,103 shares during the quarter. Illinois Municipal Retirement Fund’s holdings in Henry Schein were worth $5,430,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the business. Vanguard Personalized Indexing Management LLC raised its stake in Henry Schein by 3.5% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 4,669 shares of the company’s stock valued at $341,000 after purchasing an additional 157 shares in the last quarter. Equitable Trust Co. grew its stake in shares of Henry Schein by 3.1% in the 2nd quarter. Equitable Trust Co. now owns 5,317 shares of the company’s stock worth $388,000 after buying an additional 158 shares in the last quarter. TD Asset Management Inc increased its holdings in shares of Henry Schein by 0.8% in the 2nd quarter. TD Asset Management Inc now owns 22,016 shares of the company’s stock worth $1,608,000 after buying an additional 164 shares during the last quarter. Radnor Capital Management LLC raised its position in shares of Henry Schein by 1.6% during the 2nd quarter. Radnor Capital Management LLC now owns 11,415 shares of the company’s stock valued at $834,000 after buying an additional 180 shares in the last quarter. Finally, Simon Quick Advisors LLC raised its position in shares of Henry Schein by 5.5% during the 2nd quarter. Simon Quick Advisors LLC now owns 3,466 shares of the company’s stock valued at $253,000 after buying an additional 182 shares in the last quarter. Institutional investors own 96.62% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have weighed in on HSIC. Stifel Nicolaus reissued a “hold” rating and set a $75.00 price objective (down from $80.00) on shares of Henry Schein in a research note on Friday, July 25th. Wall Street Zen upgraded Henry Schein from a “hold” rating to a “buy” rating in a report on Saturday. Evercore ISI increased their price target on Henry Schein from $83.00 to $90.00 and gave the company an “outperform” rating in a report on Wednesday, November 5th. Weiss Ratings restated a “hold (c-)” rating on shares of Henry Schein in a research report on Friday, October 31st. Finally, Barrington Research set a $79.00 price objective on shares of Henry Schein and gave the company an “outperform” rating in a research report on Wednesday, November 5th. Five analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $76.08.

Henry Schein Price Performance

Shares of HSIC stock opened at $73.22 on Wednesday. The stock has a 50 day moving average price of $66.46 and a 200 day moving average price of $68.86. Henry Schein, Inc. has a 52-week low of $60.56 and a 52-week high of $82.49. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.78 and a current ratio of 1.41. The firm has a market capitalization of $8.62 billion, a P/E ratio of 23.62, a P/E/G ratio of 2.06 and a beta of 0.84.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, November 4th. The company reported $1.38 earnings per share for the quarter, topping analysts’ consensus estimates of $1.27 by $0.11. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The business had revenue of $3.34 billion for the quarter, compared to analyst estimates of $3.28 billion. Henry Schein has set its FY 2025 guidance at 4.880-4.960 EPS. As a group, sell-side analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.